U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins
  1. Drug Safety and Availability

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins

Breastfeeding not recommended in patients who require statins

en Español

Drug Safety Communication (PDF - 119 KB)

美国食品药品监督管理局要求取消在妊娠期不要使用降胆固醇的他汀类药物的最强烈警告;但仍建议大多数怀孕患者应停用他汀类药物建议需服用他汀类药物的患者进行母乳喂养​

07-20-2021  FDA Drug Safety Communication

Related Information

Contact FDA

For More Info
855-543-DRUG (3784) and press 4
druginfo@fda.hhs.gov

Report a Serious Problem to MedWatch
Complete and submit the report Online.
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

 

 
Back to Top